Nippon Shinyaku Co., Ltd.

4516.T
Drug Manufacturers - Specialty & Generic
2026/01/16 Updated
Market Cap: $2.4B (¥378.3B)
Stock Price: $35.41 (¥5,612)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
11.83
PER (Price Earnings Ratio)
vs Industry Avg: +2.3
1.46
PBR (Price to Book Ratio)
vs Industry Avg: +0.2
2.21%
Dividend Yield
vs Industry Avg: -0.74%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
-1.08%
Near-term
25-Day MA
-2.77%
Mid-term
75-Day MA
+33.33%
Long-term
200-Day MA
+53.65%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥5,643
Open ¥5,643
High ¥5,677
Low ¥5,575
Close ¥5,612

TRADING

Volume 361,300
Average Volume 629,779
Turnover ¥20億
Min. Purchase ¥561,200

Analyst Recommendations 8 analysts

Updated 2026/01/11
Strong Buy
0
Buy
3
3
Hold
4
4
Sell
1
1
Strong Sell
0
Target Price (Mean)
¥6,200
None
¥8,200
High
¥6,600
Median
¥2,600
Low
+4% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/01/11
4.7%
Insider Holdings
47.2%
Institutional
48.1%
Public Float
128
Institutional Holders
Insider Holdings 4.7%
Institutional 47.2%
Public Float 48.1%

Major Holders

Updated 2026/01/11
Institution Ownership Shares Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.12%
788.1K +8.75%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.73%
509.6K +12.42%
iShares Trust-iShares Core MSCI EAFE ETF
0.51%
355.1K 0.00%
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
0.29%
202.2K +24.81%
iShares Trust-iShares MSCI EAFE Small-Cap ETF
0.25%
177.0K +3.87%
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
0.23%
162.1K 0.00%

Dividend History

Updated 2026/01/11
-%
Dividend Yield
¥124
Annual Dividend
0.0%
YoY Growth
25.7%
Payout Ratio
Year Dividend Change
2025 ¥124 0.0%
2024 ¥124 +4.2%
2023 ¥119 +2.6%
2022 ¥116 +14.9%
2021 ¥101 -

Financial Performance

2026/01/11 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥137,484M ¥144,175M ¥148,255M ¥160,232M
Gross Profit ¥87,293M ¥88,195M ¥98,021M ¥109,115M
Operating Income ¥32,948M ¥30,050M ¥33,297M ¥35,451M
Pretax Income ¥33,420M ¥30,625M ¥33,945M ¥36,280M
Net Income ¥24,986M ¥22,812M ¥25,851M ¥32,558M
EPS ¥370.97 ¥338.70 ¥383.82 ¥483.40
Operating Margin 23.96% 20.84% 22.46% 22.12%
Balance Sheet
Total Assets ¥219,943M ¥237,451M ¥263,404M ¥283,637M
Total Equity ¥180,584M ¥195,624M ¥220,224M ¥247,027M
Total Liabilities ¥39,359M ¥41,827M ¥43,180M ¥36,610M
Cash ¥60,566M ¥60,047M ¥58,094M ¥55,241M
Interest-bearing Debt ¥2,713M ¥2,664M ¥2,872M ¥2,722M
Equity Ratio 82.10% 82.38% 83.61% 87.09%
D/E Ratio 0.02 0.01 0.01 0.01
Cash Flow
Operating CF ¥21,316M ¥26,170M ¥16,289M ¥36,126M
Investing CF -¥10,037M -¥17,631M -¥9,921M -¥28,877M
Financing CF -¥8,407M -¥9,605M -¥9,719M -¥9,902M
Free CF ¥12,373M ¥14,442M ¥6,640M ¥1,333M
Efficiency
ROE 13.84% 11.66% 11.74% 13.18%
ROA 11.36% 9.61% 9.81% 11.48%

Latest IR Information

  • No IR information found for this company.

    Searched stock code: 4516

Company Information

English Name Nippon Shinyaku Co., Ltd.
Japanese Name 日本新薬(株)
Stock Code 4516.T (JPX)
Sector / Industry Healthcare / Drug Manufacturers - Specialty & Generic
Employees 2,243

About

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.

Data provided by Yahoo Finance